Tree Nut Oral Immunotherapy Both Safe And Tolerable Among Preschoolers
- byDoctor News Daily Team
- 07 July, 2025
- 0 Comments
- 0 Mins
Canada: Allergic reactions are adverse reactions that occur when the body's immune system overreacts to a particular allergen. These reactions may be caused by food, insect stings, latex, medications and other substances.
A study published in The Journal of Allergy and Clinical Immunology: In Practice has highlighted that tree nut oral immunotherapy is deemed safe and tolerable for preschoolers.
The researchers of the present study mentioned that their group previously described preschool peanut oral immunotherapy (OIT) in a real-world, multicenter setting for preschoolers. The study results suggested that the therapy is safe.
This study examined whether tree nut (TN) immunotherapy is safe and tolerable in preschoolers.
TN-OIT (cashew/pistachio, walnut/pecan, hazelnut, almond, and macadamia nut) was performed in preschoolers. These had skin prick test wheal diameter ≥ 3 mm or a specific IgE level ≥ 0.35 kU/L and a convincing objective IgE-mediated reaction; there was no history of ingestion with a particular level of Ige≥5 kU/L.
Dose escalations were performed every 2 to 4 weeks till a maintenance dose of 300 mg of TN protein was reached. The modified World Allergy Organization Subcutaneous Immunotherapy Reaction Grading System recorded from 1 as mildest and five as fatal was used for recording and classifying symptoms.
The study results could be summarised as follows:
There were 92 patients starting tree nut oral immunotherapy TN-OIT ( 2018 – 2021).
Seventy-nine patients underwent single-food TN-OIT, and 13 underwent multifood TN-OIT to 2 or 3 tree nuts.
Maintenance was reached by Eighty-nine patients constituting 96.7%.
Four patients constituting 4.3%, dropped out.
Sixty-five constituting 70.7% of patients, experienced reactions during buildup with grade 1 reactions (35 patients), grade 2 reactions (30 patients), no grade 3 or 4 reactions, and 2 received epinephrine.
Further concluding, they wrote that “We find the results of the present study comparable to our previous study on peanut oral immunotherapy.”
Our study’s findings prove the safety and tolerability of TN-OIN in Preschool.
Further reading:
Real-World Safety Analysis of Preschool Tree Nut Oral Immunotherapy. https://doi.org/10.1016/j.jaip.2023.01.031
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Tags:
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!